Encompass Health Corporation
EHC
$112.67
$0.670.60%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.80B | 5.67B | 5.51B | 5.37B | 5.22B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.80B | 5.67B | 5.51B | 5.37B | 5.22B |
| Cost of Revenue | 3.32B | 3.27B | 3.19B | 3.14B | 3.06B |
| Gross Profit | 2.47B | 2.40B | 2.32B | 2.23B | 2.16B |
| SG&A Expenses | 281.50M | 278.90M | 269.50M | 266.50M | 264.40M |
| Depreciation & Amortization | 319.50M | 315.50M | 308.50M | 299.60M | 291.70M |
| Other Operating Expenses | 868.80M | 840.10M | 816.20M | 792.20M | 770.60M |
| Total Operating Expenses | 4.79B | 4.70B | 4.59B | 4.50B | 4.38B |
| Operating Income | 1.00B | 967.50M | 924.00M | 874.90M | 832.50M |
| Income Before Tax | 896.70M | 860.60M | 809.80M | 749.60M | 713.00M |
| Income Tax Expenses | 175.10M | 166.20M | 153.50M | 150.20M | 149.80M |
| Earnings from Continuing Operations | 721.60 | 694.40 | 656.30 | 599.40 | 563.20 |
| Earnings from Discontinued Operations | -1.40M | -1.70M | -2.00M | -2.80M | -11.70M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -179.20M | -170.00M | -159.60M | -140.90M | -129.10M |
| Net Income | 541.00M | 522.70M | 494.70M | 455.70M | 422.40M |
| EBIT | 1.00B | 967.50M | 924.00M | 874.90M | 832.50M |
| EBITDA | 1.32B | 1.28B | 1.23B | 1.17B | 1.12B |
| EPS Basic | 5.37 | 5.19 | 4.91 | 4.53 | 4.20 |
| Normalized Basic EPS | 3.80 | 3.67 | 3.47 | 3.35 | 3.24 |
| EPS Diluted | 5.29 | 5.12 | 4.84 | 4.46 | 4.14 |
| Normalized Diluted EPS | 3.73 | 3.60 | 3.40 | 3.27 | 3.17 |
| Average Basic Shares Outstanding | 401.60M | 401.00M | 400.30M | 399.60M | 399.10M |
| Average Diluted Shares Outstanding | 409.00M | 408.80M | 408.50M | 408.60M | 407.80M |
| Dividend Per Share | 0.70 | 0.68 | 0.66 | 0.64 | 0.62 |
| Payout Ratio | 12.77% | 12.84% | 13.12% | 13.78% | 14.37% |